{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:03:18Z","timestamp":1790344998824,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.lungcan.2026.109502","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:20:25Z","timestamp":1781886025000},"page":"109502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Enrichment of SMARCA4 mutations in lung carcinomas presenting as cancer of unknown primary"],"prefix":"10.1016","volume":"218","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5498-8981","authenticated-orcid":false,"given":"Tobias","family":"Martinot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1952-424X","authenticated-orcid":false,"given":"Lydia H.N.","family":"Schonewille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8231-3398","authenticated-orcid":false,"given":"Dina","family":"Ruano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4164-5652","authenticated-orcid":false,"given":"Elisabeth M.P.","family":"Steeghs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"van Wezel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9772-0511","authenticated-orcid":false,"given":"Willemijn S.M.E.","family":"Theelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent T.H.B.M.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1086-8108","authenticated-orcid":false,"given":"Petur","family":"Snaebjornsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egbert F.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Monkhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.lungcan.2026.109502_b0005","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1002\/cam4.1689","article-title":"Cancer of unknown primary-Epidemiological trends and relevance of comprehensive genomic profiling","volume":"7","author":"Binder","year":"2018","journal-title":"Cancer Med."},{"issue":"9824","key":"10.1016\/j.lungcan.2026.109502_b0010","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(11)61178-1","article-title":"Cancer of unknown primary site","volume":"379","author":"Pavlidis","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.lungcan.2026.109502_b0015","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0959-8049(01)00378-1","article-title":"Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992","volume":"38","author":"van de Wouw","year":"2002","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.lungcan.2026.109502_b0020","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.annonc.2022.11.013","article-title":"Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Kramer","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2026.109502_b0025","unstructured":"National Institute for Health and Care Excellence: Guidelines. In: Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin. Cardiff (UK): National Collaborating Centre for Cancer (UK); 2010."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109502_b0030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.canep.2014.03.010","article-title":"Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961-2010","volume":"38","author":"Brewster","year":"2014","journal-title":"Cancer Epidemiol."},{"issue":"11","key":"10.1016\/j.lungcan.2026.109502_b0035","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/s41416-021-01544-1","article-title":"Characterisation and outcomes of patients referred to a regional cancer of unknown primary team: a 10-year analysis","volume":"125","author":"Stares","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.lungcan.2026.109502_b0040","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2217\/cer-2017-0104","article-title":"Pretreatment costs of care and time to initial treatment for patients with cancer of unknown primary","volume":"7","author":"Walker","year":"2018","journal-title":"J. Comp. Eff. Res."},{"key":"10.1016\/j.lungcan.2026.109502_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103868","article-title":"International consensus on the initial diagnostic workup of cancer of unknown primary","volume":"181","author":"van der Strate","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.lungcan.2026.109502_b0050","unstructured":"Federatie Medisch Specialisten. Primaire tumor onbekend. 22-10-2012 ed.; 2012."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109502_b0055","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41596-023-00933-5","article-title":"Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practice","volume":"19","author":"Samsom","year":"2024","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109502_b0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/path.5988","article-title":"Feasibility of whole-genome sequencing-based tumor diagnostics in routine pathology practice","volume":"258","author":"Samsom","year":"2022","journal-title":"J. Pathol."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109502_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100611","article-title":"Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics","volume":"7","author":"Schipper","year":"2022","journal-title":"ESMO Open"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109502_b0070","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12920-020-00814-w","article-title":"Study protocol: whole genome sequencing Implementation in standard Diagnostics for every cancer patient (WIDE)","volume":"13","author":"Samsom","year":"2020","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/j.lungcan.2026.109502_b0075","article-title":"Real-world clinical utility of tumor whole-genome sequencing in solid cancers","author":"van Putten","year":"2026","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109502_b0080","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1038\/s41467-025-59661-x","article-title":"Whole genome sequencing improves tissue-of-origin diagnosis and treatment options for cancer of unknown primary","volume":"16","author":"Rebello","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109502_b0085","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1038\/s41467-022-31666-w","article-title":"Machine learning-based tissue of origin classification for cancer of unknown primary diagnostics using genome-wide mutation features","volume":"13","author":"Nguyen","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lungcan.2026.109502_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.634563","article-title":"The Diminishing Importance of Primary Site Identification in Cancer of unknown Primary: a Canadian Single-Center Experience","volume":"11","author":"Wong","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lungcan.2026.109502_b0095","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-3-540-31203-1_15","article-title":"Cancer of unknown primary","volume":"170","author":"Freudenberg","year":"2008","journal-title":"Recent Results Cancer Res."},{"issue":"5","key":"10.1016\/j.lungcan.2026.109502_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.105069","article-title":"Impact of whole genome sequencing on the care pathway for patients with cancer of unknown primary","volume":"10","author":"Droogers","year":"2025","journal-title":"ESMO Open"},{"issue":"7","key":"10.1016\/j.lungcan.2026.109502_b0105","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/ijc.33328","article-title":"Alcohol consumption, cigarette smoking and cancer of unknown primary risk: results from the Netherlands Cohort Study","volume":"148","author":"Hermans","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.lungcan.2026.109502_b0110","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1002\/ijc.28874","article-title":"Risk factors for cancers of unknown primary site: results from the prospective EPIC cohort","volume":"135","author":"Kaaks","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109502_b0115","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/ijc.28969","article-title":"Smoking and body mass index as risk factors for subtypes of cancer of unknown primary","volume":"136","author":"Hemminki","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109502_b0120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13000-025-01738-8","article-title":"Usefulness of BRG1 immunostaining in detecting SMARCA4 deficiency in \u201cso-called\u201d cancers of unknown primary in daily pathology practice","volume":"21","author":"Hasegawa","year":"2025","journal-title":"Diagn. Pathol."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109502_b0125","doi-asserted-by":"crossref","DOI":"10.3390\/cells10081920","article-title":"Perspectives and issues in the Assessment of SMARCA4 Deficiency in the Management of Lung Cancer Patients","volume":"10","author":"Armon","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.lungcan.2026.109502_b0130","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4161\/epi.3.2.6153","article-title":"Involvement of the chromatin-remodeling factor BRG1\/SMARCA4 in human cancer","volume":"3","author":"Medina","year":"2008","journal-title":"Epigenetics"},{"key":"10.1016\/j.lungcan.2026.109502_b0135","unstructured":"Yoshida A BJ, Le Loarer F, Jain D, Rekhtman N. Thoracic SMARCA4-deficient undifferentiated tumour. WHO Classification of Tumours Editorial Board. Thoracic tumours [Internet]. 5. Lyon (France): International Agency for Research on Cancer; 2021."},{"issue":"10","key":"10.1016\/j.lungcan.2026.109502_b0140","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/modpathol.2017.61","article-title":"SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior","volume":"30","author":"Sauter","year":"2017","journal-title":"Mod. Pathol."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109502_b0145","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jtho.2019.10.023","article-title":"SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas rather than Primary Thoracic Sarcomas","volume":"15","author":"Rekhtman","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.109502_b0150","article-title":"Understanding the clinical and molecular phenotype of cancer of unknown primary (CUP) with a lung cancer profile","volume":"43(16_suppl):e20567\u2013e20567","author":"Williams","year":"2025","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109502_b0155","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00432-025-06293-9","article-title":"Clinicopathological and genomic analysis of SWI\/SNF chromatin remodeling abnormalities with a focus on SMARCA4 in cancer of unknown primary","volume":"151","author":"Tono","year":"2025","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.109502_b0160","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.anndiagpath.2016.10.006","article-title":"SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens","volume":"26","author":"Herpel","year":"2017","journal-title":"Ann. Diagn. Pathol."},{"issue":"7781","key":"10.1016\/j.lungcan.2026.109502_b0165","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41586-019-1689-y","article-title":"Pan-cancer whole-genome analyses of metastatic solid tumours","volume":"575","author":"Priestley","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.lungcan.2026.109502_b0170","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","article-title":"The nf-core framework for community-curated bioinformatics pipelines","volume":"38","author":"Ewels","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"7463","key":"10.1016\/j.lungcan.2026.109502_b0175","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.lungcan.2026.109502_b0180","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1002\/onco.13597","article-title":"Comprehensive Genomic Profiling of Carcinoma of unknown Primary Origin: Retrospective Molecular Classification considering the CUPISCO Study Design","volume":"26","author":"Ross","year":"2021","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.lungcan.2026.109502_b0185","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The Cancer Genome Atlas Pan-Cancer analysis project","volume":"45","author":"Chang","year":"2013","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109502_b0190","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12931-021-01871-0","article-title":"Mutational signature analysis in non-small cell lung cancer patients with a high tumor mutational burden","volume":"22","author":"van den Heuvel","year":"2021","journal-title":"Respir. Res."},{"issue":"21","key":"10.1016\/j.lungcan.2026.109502_b0195","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1158\/1078-0432.CCR-20-1825","article-title":"The Genomic Landscape of SMARCA4 Alterations and Associations with Outcomes in patients with Lung Cancer","volume":"26","author":"Schoenfeld","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109502_b0200","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.21037\/tlcr-2025-305","article-title":"STK11\/KEAP1 co-mutations in SMARCA4-mutant advanced non-small cell lung cancer: genetic characteristics and impact on immunotherapy efficacy","volume":"14","author":"Dong","year":"2025","journal-title":"Transl Lung Cancer Res."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226005635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226005635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:28:33Z","timestamp":1790342913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226005635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":40,"alternative-id":["S0169500226005635"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109502","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enrichment of SMARCA4 mutations in lung carcinomas presenting as cancer of unknown primary","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109502","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109502"}}